air pollutants are reported to increase the specific ige response to allergens. clinical tests and immonoblotting were performed with pollen grains of spartium junceum. to identify allergens and to determine the effect of air pollutants on the allergenicity of the pollen extracts, the pollen extracts were injected intraperitoneally and intracutaneously to guinea pigs. injection of the pollen ex...

background: hyper ige syndrome (hies) is a rare primary immune deficiency, described as job`s syndrome characterized by increased serum levels of ige, eczema, recurrent cutaneous and pulmonary infections. in this paper, we presented a case of hyper ige syndrome.case presentation: a 16-year-old iranian boy presented with a one year history of skin lesions in knees and elbows was diagnosed of pso...

BackgroundIgE causes anaphylaxis in type I hypersensitivity diseases by activating degranulation of effector cells such as mast and basophils. The mechanisms that control IgE activity prevent under normal conditions are still enigmatic.ObjectiveWe aimed to unravel how anti-IgE autoantibodies induced we understand their role regulating serum level allergic anaphylaxis.MethodsWe immunized mice wi...

IgE, the antibody that mediates allergic responses, acts as part of a self-regulating protein network. Its unique effector functions are controlled through interactions of its Fc region with two cellular receptors, FcεRI on mast cells and basophils and CD23 on B cells. IgE cross-linked by allergen triggers mast cell activation via FcεRI, whereas IgE-CD23 interactions control IgE expression leve...

Events mediated by immunoglobulin E (IgE) may be related to platelet activation and aggregation, and there may be an association between IgE and pulmonary thromboembolism (PTE). Fourteen patients with PTE were studied with regard to serum concentrations of IgE, IgA, IgG, IgM, fibrinogen, and D-dimer and with regard to blood neutrophil, lymphocyte, platelet, and eosinophil counts during acute an...

Omalizumab, an anti-IgE antibody, used to treat severe allergic asthma and chronic idiopathic urticaria, binds to IgE in blood or membrane-bound on B lymphocytes but not to IgE bound to its high (FcεRI) or low (CD23) affinity receptor. Mutagenesis studies indicate overlapping FcεRI and omalizumab-binding sites in the Cε3 domain, but crystallographic studies show FcεRI and CD23-binding sites tha...

In vivo experiments using anti-IgE antibodies have clearly documented that they inhibit IgE production. In vitro experiments showed that not only IgE synthesis but also the effector phase of the allergic response may be influenced, because anti-IgE antibodies can prevent basophil sensitiziation with IgE or even remove IgE-receptorbound IgE molecules. However, the question remains whether natura...